Status:
RECRUITING
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
Lead Sponsor:
Centre Hospitalier Universitaire de la Guadeloupe
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Prostatic Neoplasm
Adenocarcinoma
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographi...
Detailed Description
There is a lack of information to predict the course of prostate cancer following its initial diagnosis; in other words, why some are indolent and evolve very slowly and others are aggressive, evolve ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult patients with incident case of prostate cancer Patient consulting the University Hospital of Guadeloupe or the University Hospital of Rennes Patient who resides in the departments of Guadeloupe or Martinique or the community of Saint-Martin or in Britany Patient affiliated or beneficiary of the social security signed consent
Exclusion
- Physical or mental health judjed by the investigator as precluding participation in the research Protected adults (guardianship, curatorship, safeguard of justice).
Key Trial Info
Start Date :
February 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2039
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06046131
Start Date
February 28 2023
End Date
February 28 2039
Last Update
November 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU of Rennes
Rennes, Ille-et-Vilaine, France, 35000
2
CHU of Guadeloupe
Pointe-à-Pitre, Guadeloupe, Guadeloupe, 97159